title: The importance of IGRA in patients candidates for biological therapy.
authors.affiliation: Gastroenterology Department of Centro Hospitalar do Alto Ave, Guimarães, Portugal. Electronic address: jcotter@chaa.min-saude.pt.
authors.forename: José
authors.initials: J
authors.lastname: Cotter
authors.forename: Bruno
authors.initials: B
authors.lastname: Rosa
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male; D014376:Tuberculosis / Q000139:chemically induced*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized